Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 Oct;92(2):357–362. doi: 10.1111/j.1476-5381.1987.tb11331.x

Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks.

J A Gray 1, A R Green 1
PMCID: PMC1853662  PMID: 2823949

Abstract

1 Addition of baclofen to a medium containing slices of mouse frontal cortex inhibited the potassium-evoked release of 5-hydroxytryptamine (5-HT) in a concentration-dependent manner. The degree of inhibition was increased in frontal cortex tissue taken from animals treated for 14 days with amitriptyline (10 mg kg-1, twice daily) at all concentrations of baclofen tested (10(-6) M-10(-4) M). 2 Administration of either desipramine, mianserin or zimeldine (10 mg kg-1 daily) for 14 days also approximately doubled the degree of inhibition evoked by addition of baclofen (10(-5) M) to the medium. 3 One day of treatment with the antidepressant drugs did not alter the inhibitory effect of baclofen on K+-evoked 5-HT release. 4 Addition of the antidepressant drugs to the medium had no effect on the K+-evoked release of 5-HT. 5 Repeated administration of electroconvulsive shock (5 seizures spread out over 10 days), like amitriptyline, produced a significant enhancement of the baclofen-induced inhibition of 5-HT release over the range of baclofen concentrations studied. A single electroconvulsive shock had no effect. 6 These data suggest that repeated administration of the antidepressant drugs or electroconvulsive shock increases the function of the gamma-aminobutyric acid (GABA)B receptor in the frontal cortex modulating 5-HT release and are consistent with the finding of increased GABAB receptor number in this region following various antidepressant treatments.

Full text

PDF
357

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowery N. G., Hill D. R., Hudson A. L., Doble A., Middlemiss D. N., Shaw J., Turnbull M. (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature. 1980 Jan 3;283(5742):92–94. doi: 10.1038/283092a0. [DOI] [PubMed] [Google Scholar]
  2. Goodwin G. M., De Souza R. J., Green A. R. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Psychopharmacology (Berl) 1987;91(4):500–505. doi: 10.1007/BF00216018. [DOI] [PubMed] [Google Scholar]
  3. Goodwin G. M., Green A. R., Johnson P. 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol. 1984 Sep;83(1):235–242. doi: 10.1111/j.1476-5381.1984.tb10140.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gray J. A., Green A. R. GABAB-receptor mediated inhibition of potassium-evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex. Br J Pharmacol. 1987 Jul;91(3):517–522. doi: 10.1111/j.1476-5381.1987.tb11244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Korf J., Venema K. Desmethylimipramine enhances the release of endogenous GABA and other neurotransmitter amino acids from the rat thalamus. J Neurochem. 1983 Apr;40(4):946–950. doi: 10.1111/j.1471-4159.1983.tb08078.x. [DOI] [PubMed] [Google Scholar]
  6. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  7. Lloyd K. G., Thuret F., Pilc A. Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J Pharmacol Exp Ther. 1985 Oct;235(1):191–199. [PubMed] [Google Scholar]
  8. Molyneux S. G., Clarke E. E. Precise determination of 5-hydroxytryptamine in platelets and platelet-poor plasma. Clin Chem. 1985 Sep;31(9):1573–1574. [PubMed] [Google Scholar]
  9. Pilc A., Lloyd K. G. Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action. Life Sci. 1984 Nov 19;35(21):2149–2154. doi: 10.1016/0024-3205(84)90515-0. [DOI] [PubMed] [Google Scholar]
  10. Schlicker E., Classen K., Göthert M. GABAB receptor-mediated inhibition of serotonin release in the rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(2):99–105. doi: 10.1007/BF00517304. [DOI] [PubMed] [Google Scholar]
  11. Sherman A. D., Petty F. Additivity of neurochemical changes in learned helplessness and imipramine. Behav Neural Biol. 1982 Aug;35(4):344–353. doi: 10.1016/s0163-1047(82)90978-5. [DOI] [PubMed] [Google Scholar]
  12. Suzdak P. D., Gianutsos G. Effect of chronic imipramine or baclofen on GABA-B binding and cyclic AMP production in cerebral cortex. Eur J Pharmacol. 1986 Nov 12;131(1):129–133. doi: 10.1016/0014-2999(86)90526-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES